Literature DB >> 15790783

Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome.

Marc Tardieu1, Catherine Lacroix, Bénédicte Neven, Pierre Bordigoni, Geneviève de Saint Basile, Stéphane Blanche, Alain Fischer.   

Abstract

Three patients with Chediak-Higashi syndrome underwent allogeneic bone marrow transplantation between the ages of 2 years 9 months and 7 years. The outcome was uneventful, with sustained mixed chimerism. No subsequent recurrent infections or hemophagocytic syndrome were observed. At the age of 22 to 24 years, these 3 patients developed a neurologic deficit combining difficulty walking, loss of balance, and tremor. Neurologic evaluation demonstrated cerebellar ataxia and signs of peripheral neuropathy. Moderate axon loss and rarefaction of large myelinated fibers were observed on semithin sections of peripheral nerve. Cerebellar atrophy was detected by cerebral magnetic resonance imaging in 2 patients. We also reviewed the very long-term outcome of the other 11 patients with Chediak-Higashi syndrome who had received bone marrow transplants at our center since 1981. All displayed neurologic deficits or low cognitive abilities.

Entities:  

Mesh:

Year:  2005        PMID: 15790783     DOI: 10.1182/blood-2005-01-0319

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  Chediak-Higashi syndrome presenting as young-onset levodopa-responsive parkinsonism.

Authors:  Vikas Bhambhani; Wendy J Introne; Codrin Lungu; Andrew Cullinane; Camilo Toro
Journal:  Mov Disord       Date:  2013-02       Impact factor: 10.338

2.  Parkinsonism and Other Movement Disorders Associated with Chediak-Higashi Syndrome: Case Report and Systematic Literature Review.

Authors:  Bettina Balint; Kailash P Bhatia
Journal:  Mov Disord Clin Pract       Date:  2015-01-14

3.  Chediak-Higashi syndrome: a review of the past, present, and future.

Authors:  Prashant Sharma; Elena-Raluca Nicoli; Jenny Serra-Vinardell; Marie Morimoto; Camilo Toro; May Christine V Malicdan; Wendy J Introne
Journal:  Drug Discov Today Dis Models       Date:  2019-12-09

4.  Regulation of synaptic transmission by RAB-3 and RAB-27 in Caenorhabditis elegans.

Authors:  Timothy R Mahoney; Qiang Liu; Takashi Itoh; Shuo Luo; Gayla Hadwiger; Rose Vincent; Zhao-Wen Wang; Mitsunori Fukuda; Michael L Nonet
Journal:  Mol Biol Cell       Date:  2006-03-29       Impact factor: 4.138

Review 5.  Hematopoietic stem cell transplantation for primary immunodeficiencies.

Authors:  Elizabeth Kang; Andrew Gennery
Journal:  Hematol Oncol Clin North Am       Date:  2014-09-16       Impact factor: 3.722

6.  Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.

Authors:  Thomas R Bauer; Rima L Adler; Dennis D Hickstein
Journal:  ILAR J       Date:  2009

7.  Two novel mutations identified in an african-american child with chediak-higashi syndrome.

Authors:  Kerry Morrone; Yanhua Wang; Marjan Huizing; Elie Sutton; James G White; William A Gahl; Karen Moody
Journal:  Case Rep Med       Date:  2010-03-24

8.  Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challenge.

Authors:  Nada Jabado; Christine McCusker; Genevieve de Saint Basile
Journal:  Allergy Asthma Clin Immunol       Date:  2005-12-15       Impact factor: 3.406

9.  Elevated oxidative membrane damage associated with genetic modifiers of Lyst-mutant phenotypes.

Authors:  Colleen M Trantow; Adam Hedberg-Buenz; Sachiyo Iwashita; Steven A Moore; Michael G Anderson
Journal:  PLoS Genet       Date:  2010-07-01       Impact factor: 5.917

10.  Four cases of Chédiak-Higashi syndrome.

Authors:  Ana Paula de Azambuja; Bárbara do Nascimento; Samuel Ricardo Comar; Gisele Loth; Lisandro Lima Ribeiro; Carmem Bonfim; Mara Pianovski; José Zanis Neto; Mariester Malvezzi
Journal:  Rev Bras Hematol Hemoter       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.